<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03911908</url>
  </required_header>
  <id_info>
    <org_study_id>2018-13666</org_study_id>
    <secondary_id>U1111-1231-2797</secondary_id>
    <nct_id>NCT03911908</nct_id>
  </id_info>
  <brief_title>Impact of NIRS-guided Cardiopulmonary Resuscitation After Cardiac Arrest on Resuscitation Rate</brief_title>
  <acronym>NICA</acronym>
  <official_title>Impact of a NIRS-guided Cardiopulmonary Resuscitation Algorithm Compared to the Current ERC-guideline Algorithm on ROSC Rate and Patient Outcome After In-hospital and Out-of-hospital Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Serge Thal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johannes Gutenberg University Mainz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sudden cardiac death is one of the main causes of morbidity and mortality worldwide. Cardiac
      arrest requires prompt intervention by cardiopulmonary resuscitation (CPR). The resuscitation
      guidelines are the current recommendations for CPR and are revised by expert panels such as
      the &quot;European Resuscitation Council (ERC)&quot;.

      Up to now, a parameter for assessing the quality of CPR is missing and further monitoring
      methods are urgently needed.

      Near-infrared spectroscopy (NIRS) is a portable method for measuring regional oxygen levels
      in the brain. Recent clinical trials suggest that cerebral oxygenation measured by NIRS may
      correlate with survival and outcome after cardiac arrest.

      The investigators propose that NIRS technology may not only be suitable to determine or
      predict the outcome of the patients, but could also be a useful tool to guide the CPR
      providers to optimize the CPR techniques and guide the individual treatments/interventions.

      The present study was therefore designed to determine if NIRS guided CPR with the aim to
      optimize NIRS values is superior compared to the current standard practice according to
      published CPR guidelines (return of spontaneous circulation [ROSC] rate, short and long-term
      cerebral performance).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Does near-infrared spectroscopy (NIRS) technology based advanced cardiac life support improve cardiopulmonary resuscitation (CPR) quality in patients (in-house [IHCA] and out-of-hospital cardiac arrest [OHCA], randomized enrollment immediately with CPR) and thereby improve return of spontaneous circulation (ROSC) rate (primary outcome) and patient outcome compared to European Resuscitation Council (ERC)-based CPR (concealed NIRS recording).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>On group will have NIRS reading available to adjust CPR interventions, whereas the control group will not be able use NIRS readings (masked by cover)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>successful cardiopulmonary resuscitation (CPR)</measure>
    <time_frame>DAY 1</time_frame>
    <description>Influence of the intervention on the number of patients with successful return of spontaneous circulation (ROSC) during cardiopulmonary resuscitation (CPR) [ROSC: yes/no]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time-to-ROSC</measure>
    <time_frame>DAY 1</time_frame>
    <description>Time from start of cardiopulmonary resuscitation (CPR) until successful return of spontaneous circulation (ROSC) [min]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral Performance Category (CPC) after successful return of spontaneous circulation (ROSC)</measure>
    <time_frame>DAY 30, DAY 180, DAY 360</time_frame>
    <description>Neurofunctional recovery, total score, range: 1-5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow Outcome Scale Extended (GOS-E) after successful return of spontaneous circulation (ROSC)</measure>
    <time_frame>DAY 30, DAY 180, DAY 360 after successful return of spontaneous circulation (ROSC)</time_frame>
    <description>Neurofunctional recovery, total score, range: 1-8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Bathel-Index (Barthel) after successful return of spontaneous circulation (ROSC)</measure>
    <time_frame>Discharge from intensive care unit (variable time point, depending on condition of patient)</time_frame>
    <description>Neurofunctional recovery, total score, range: 0-100</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Neuron Specific Enolase (NSE) blood level after successful return of spontaneous circulation (ROSC)</measure>
    <time_frame>DAY 1, DAY 2, DAY 3, DAY 4</time_frame>
    <description>NSE as marker for brain damage after cardiac arrest</description>
  </other_outcome>
  <other_outcome>
    <measure>S100B blood level after successful return of spontaneous circulation (ROSC)</measure>
    <time_frame>DAY 1, DAY 2, DAY 3, DAY 4</time_frame>
    <description>S100B as marker for brain damage after cardiac arrest</description>
  </other_outcome>
  <other_outcome>
    <measure>plasminogen activator inhibitor 1/2 (PAI1/2) blood level after successful return of spontaneous circulation (ROSC) after successful return of spontaneous circulation (ROSC) after successful return of spontaneous circulation (ROSC)</measure>
    <time_frame>DAY 1, DAY 2, DAY 3, DAY 4</time_frame>
    <description>PAI1/2 as marker for brain damage after cardiac arrest</description>
  </other_outcome>
  <other_outcome>
    <measure>proBNDF/BDNF blood level after successful return of spontaneous circulation (ROSC)</measure>
    <time_frame>DAY 1, DAY 2, DAY 3, DAY 4</time_frame>
    <description>proBNDF/BDNF as marker for brain damage after cardiac arrest</description>
  </other_outcome>
  <other_outcome>
    <measure>Neurofilament blood level after successful return of spontaneous circulation (ROSC)</measure>
    <time_frame>DAY 1, DAY 2, DAY 3, DAY 4</time_frame>
    <description>Neurofilament as marker for brain damage after cardiac arrest</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Cardiac Arrest</condition>
  <condition>Cardiopulmonary Arrest With Successful Resuscitation</condition>
  <condition>Cerebral Oxygenation</condition>
  <arm_group>
    <arm_group_label>ERC guided CPR (intervention/NIRS group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CPR protocol according to current ERC guidelines (2015)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ERC-based CPR (control group)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>modified CPR protocol based on current ERC guidelines (2015), extended by evaluation of NIRS readings and interventions to optimize CPR quality</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Cerebral oximetry (near infrared) based CPR-Algorithm</intervention_name>
    <description>If NIRS values do not increase over time until ROSC (target: &gt;40 % after 10 min), interventions are suggested in a modified CPR/NIRS algorithm.</description>
    <arm_group_label>ERC guided CPR (intervention/NIRS group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a cardiac arrest from the age of 18 years (in and out-of-hospital
             cardiac arrest)

        Exclusion Criteria:

          -  post-traumatic cardiac arrest

          -  non-fitting NIRS sensor (size)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Serge C Thal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Serge C Thal, MD</last_name>
    <phone>+49 6131 17</phone>
    <phone_ext>6754</phone_ext>
    <email>thal@uni-mainz.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical Center of the Johannes Gutenberg-University Mainz</name>
      <address>
        <city>Mainz</city>
        <state>Rheinland-Pfalz</state>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serge C Thal, MD PhD</last_name>
      <phone>+49 6131 17</phone>
      <phone_ext>6754</phone_ext>
      <email>thal@uni-mainz.de</email>
    </contact>
    <contact_backup>
      <last_name>Nicole Didion, MD</last_name>
      <phone>+49 6131 17</phone>
      <phone_ext>4326</phone_ext>
      <email>didion@uni-mainz.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>April 8, 2019</study_first_submitted>
  <study_first_submitted_qc>April 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2019</study_first_posted>
  <last_update_submitted>July 24, 2019</last_update_submitted>
  <last_update_submitted_qc>July 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Johannes Gutenberg University Mainz</investigator_affiliation>
    <investigator_full_name>Dr. Serge Thal</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>near-infrared spectroscopy</keyword>
  <keyword>cardiopulmonary resuscitation</keyword>
  <keyword>cardiac arrest</keyword>
  <keyword>cerebral oximetry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

